Clinical Trial Update: PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 clinical trial evaluating the safety, PK/PD, and efficacy of Gefurulimab in pediatric patients with AChR-positive generalized mya…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Gefurulimab

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Generalized Myasthenia Gravis, gMG | Phase 3 | Status: RECRUITING